Zhijuan Lin
Shuhua Yi
zhifeng li
Lingyan Ping
Xiaohua He
Liyuan Fan
Haifeng Yu
Zhong Zheng
Wei Xu
Feili Chen
Ying Xie
Bi-yun Chen
Huilai Zhang
Li Wang
Kaiyang Ding
WENYU LI
Haiyan Yang
Weili Zhao
Lugui Qiu
Zhiming Li
Yuqin Song
Bing Xu
Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing , China, Nanjing, China, Nanjing, China
Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, China
Department of Lymphoma, Guangdong Academy of Medical Science, Guangdong Provincial People's Hospital, Guangdong, China
Shanghai Institute of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai, China
Lymphoma Division, Guangdong Provincal People's Hospital, Guangdong Academy of medical sciences, Guangzhou, China
Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
The First Affiliated Hospital of Xiamen University, xiamen, China
Department of Lymphatic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences（Zhejiang Cancer Hospital），Institute of Basic Medicine and Cancer（IBMC），Chinese Academy of Sciences, Hangzhou, China
Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, guangzhou, China
Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
Department of Hematology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China
Shanghai Institute of Hematology, Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, guangzhou, China
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
Zhejiang Cancer Hospital, Hangzhou, China
Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China
China
N/A
Oncology (ONC)
Follicular lymphoma
B cell lymphomas
N/A
Rituximab
N/A
Cohort
NA
N/A
N/A
N/A